• About
  • What is Gas Station Heroin
  • News and Alerts
  • Resources
    • Health and Science
    • Policy and Enforcement
    • Concentrated 7-OH Opioid Products Database

SGSH Weekly Wire: Natural Kratom vs. Synthetic 7-OH

Last week, the Food and Drug Administration (FDA) took a historic step to protect American communities by recommending that concentrated 7-hydroxymitragynine (7-OH) products be classified as a Schedule I substance under the Controlled Substances Act.

Here’s why that matters.

Natural kratom leaf — harvested from the Southeast Asian Mitragyna speciosa tree — has been used safely for centuries. It contains trace amounts of 7-OH, but nowhere near the levels found in the synthetic, concentrated 7OH opioid products flooding U.S. gas stations, and wellness shops. As warned by FDA Commissioner Dr. Makary, these dangerous 7-OH products are 13 times more potent than morphine, presenting extreme risks of addiction and overdose.

The FDA was clear: It is not targeting natural kratom leaf products, which millions of Americans consume in forms like capsules, teas, liquids, and powders with minimal health concerns. Instead, the warning and scheduling recommendation applies only to the highly concentrated 7-OH opioids being deceptively marketed as “kratom” — products that bear no resemblance to the natural leaf.

Some lobbyists have tried to defend these synthetic opioids. Dr. Michelle Ross, who is an advisor to a 7-OH trade group, even claimed: “I would much rather see someone take 7-OH than a fentanyl tablet.”

Their scheme is clear. The 7-OH lobby is advocating for replacing one highly addictive illegal drug with another — sold in smoke shops and convenience stores for $6 a pill, without restriction. These products are driving a new, fourth wave of the opioid crisis. Unlike the 7‑OH lobby, our coalition doesn’t want to see anyone consuming dangerous, chemically altered substances. We are in full alignment with the FDA that we must act swiftly and decisively to stop the next wave of addiction before it’s too late.

The FDA’s action marks a critical turning point in stopping the Gas Station Heroin crisis. We’ll be watching closely as the DEA considers this recommendation and urging swift adoption to keep American families safe.

←The FDA recommends scheduling kratom’s 7-OH under the Controlled Substances Act
Products with opioid-like effects sold at gas stations may be banned as illicit substances→

Comments

One response to “SGSH Weekly Wire: Natural Kratom vs. Synthetic 7-OH”

  1. Paul Kemp Avatar
    August 7, 2025
    Paul Kemp

    As one of the founding members of a grassroots coalition formed to protect natural Mitragyna speciosa when early bans were proposed in 2014, I support this strong action by the FDA to remove these little tested synthetic opioid products from wide public access. Improper labeling, alone, is illegal and is confusing the public — and, importantly, endangering our access to the safe natural leaf, which millions rely on (just as we do our daily coffee, tea, or energy drinks).

    7-OH and other isolates are NOT Kratom, nor are they proven safe by
    FDA’s standards!

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

More posts

  • Illegal Drug Manufacturers Cook Up Fake Studies to Promote Dangerous Gas Station Heroin Products As Safe

    July 10, 2025
  • FDA Report: Synthetic 7-OH Products Pose Severe Opioid Risks

    August 8, 2025
  • America’s Top Public Health Officials: the Synthetic 7-OH Threat

    August 7, 2025
  • Products with opioid-like effects sold at gas stations may be banned as illicit substances

    August 6, 2025
  • SGSH Weekly Wire: Natural Kratom vs. Synthetic 7-OH

    August 6, 2025
Stop Gas Station Heroin

.

  • Facebook
  • Instagram
  • X
  • LinkedIn